Chung Hoow Kok

25PUBLICATIONS
89CO-AUTHORS
Cancer cell biologyPredictive and prognostic markersGenomicsHaematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 11, 2026
Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and nilotinib.

|May 18, 2026
Elevated desmoglein-2 expression in multiple myeloma is a prognostic marker across genomic subtypes with impact on high-risk cytogenetics and a distinct gene expression profile.

|Jan 01, 2026
Caspase-2 deficiency drives pathogenic liver polyploidy and increases age-associated hepatocellular carcinoma in mice.

Loretta Dorstyn, Yoon Lim, Jack Scanlan

|Nov 17, 2025
Evaluating NGS variant callers in a challenging genomic context with a focus on the PRSS1-PRSS2 locus for hereditary pancreatitis.

Yasir Kusay, Denghao Wu, Sunita Mc De Sousa

|Sep 02, 2025
Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.

Naranie Shanmuganathan, David T Yeung, Carol Wadham

|May 22, 2025
RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm.

Chung Hoow Kok, Aref Al-Kali, Daniel Thomas

Pageof 5

Frequent Collaborators

9 joint publications

Mithun Vinod Shah

8 joint publications

Devendra K Hiwase

8 joint publications

Hamish Scott

7 joint publications

Christopher N Hahn